Buspirone vs. Haloperidol: A Double-Blind Trial for Agitation in a Nursing Home Population With Alzheimer's Disease.

Am J Geriatr Psychiatry

Section on Geriatric Psychiatry, Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD 20892.

Published: August 2012

The authors report on a pilot double-blind comparison of buspirone with haloperidol in the treatment of agitation manifested by physical tension and motor activity in Alzheimer's disease (AD). A group of 26 nursing home residents underwent a 10-week comparison of 15 mg buspirone (n = 12) vs. 1.5 mg haloperidol (n = 14) per day. Tension and anxiety decreased to a greater extent in those patients who were treated with buspirone. Although it is not possible to draw definitive conclusions from a treatment study that does not include a placebo group, these findings suggest the potential value of further clinical research on buspirone in managing agitation in AD.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00019442-199622430-00011DOI Listing

Publication Analysis

Top Keywords

buspirone haloperidol
12
alzheimer's disease
8
comparison buspirone
8
buspirone
5
haloperidol double-blind
4
double-blind trial
4
trial agitation
4
agitation nursing
4
nursing population
4
population alzheimer's
4

Similar Publications

Risk Assessment of Psychotropic Drugs on Mitochondrial Function Using In Vitro Assays.

Biomedicines

December 2023

Department of Pharmaceutical Sciences, Barry & Judy Silverman College of Pharmacy, Nova Southeastern University, 3200 South University Drive, Ft. Lauderdale, FL 33328-2018, USA.

Article Synopsis
  • This study explores how 22 psychotropic drugs affect mitochondrial function, specifically looking at their potential to cause organ toxicity.
  • Several drugs were found to inhibit the electron transport chain (ETC) or act as uncouplers, with varying levels of cytotoxicity identified in HepG2 cells and isolated rat liver mitochondria.
  • The findings help clarify the molecular mechanisms behind drug-induced mitochondrial toxicity, which can inform safer clinical drug choices.
View Article and Find Full Text PDF

People living with dementia commonly experience anxiety, which is often challenging to manage. We investigated the effectiveness of treatments for the management of anxiety in this population. We conducted a systematic review and meta-analysis of randomised controlled trials, and searched EMBASE, CINAHL, MEDLINE and PsycInfo.

View Article and Find Full Text PDF

Effects of trazodone and dexmedetomidine on fentanyl-mediated reduction of isoflurane minimum alveolar concentration in cats.

Vet Anaesth Analg

January 2024

Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, CA, USA.

Objective: To screen modulators of biogenic amine (BA) neurotransmission for the ability to cause fentanyl to decrease isoflurane minimum alveolar concentration (MAC) in cats, and to test whether fentanyl plus a combination of modulators decreases isoflurane MAC more than fentanyl alone.

Study Design: Prospective, experimental study.

Animals: A total of six adult male Domestic Short Hair cats.

View Article and Find Full Text PDF

Background: Olanzapine (OLA) is an atypical second-generation antipsychotic that exhibits significant pharmacokinetic variability. We retrospectively investigated the effects of age, sex, and specific comedications on OLA pharmacokinetics in Chinese patients with schizophrenia.

Methods: Data on sex, age, and OLA dosage and steady-state plasma concentrations of 386 patients with schizophrenia (who have received OLA or a comedication of OLA with a psychotherapeutic drug) were collected and analyzed.

View Article and Find Full Text PDF

Inhalant (e.g. toluene) misuse by adolescents has been linked to psychosis and persistent cognitive deficits.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!